Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
At the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Conflicting points concerning drugs, carrier solution and optimal temperature for hyperthermic intraperitoneal chemotherapy (HIPEC) were discussed.
Kusamura
Shigeki
S
Department of Surgery, National Cancer Institute of Milan, Italy.
Dominique
Elias
E
Baratti
Dario
D
Younan
Rami
R
Deraco
Marcello
M
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D004337:Drug Carriers; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D007263:Infusions, Parenteral; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000601:surgery*
D000970:Antineoplastic Agents; D004337:Drug Carriers